Tiantu Capital

Tiantu Capital (天图资本 / 天图投资) is a Chinese venture capital firm with a notable track record in consumer brand investments. Per 峰瑞资本 (FreeS Fund) reporting from 2017-2021, it led or participated in several well-known deals: it co-invested with FreeS in matcha snack brand Guancha (关茶) at the angel and Pre-A stages, and led both the Series A and A+ rounds in instant coffee brand Saturnbird (三顿半) in 2019, with FreeS following on as a returning shareholder . More recently, 五源资本 (5Y Capital) reported that Tiantu led the angel rounds of biotech startups LaiMang Bio (来芒生物) and PAM2L Biotechnologies in 2022, and continued to back LaiMang in a 2024 follow-on round . The firm's investment scope spans food and beverage brands to biotech, reflecting a strategy that 峰瑞资本 once framed as positioning innovation around consumer demand .